About this trial
The consumption of an adequate quantity of protein in the diet is essential to maintain a healthy body composition and functioning. It is also well established that all proteins are not equal regarding their ability to promote health benefits. Recently, we have innovated in that matter by showing that under the context of high intake of dietary fat, the dairy protein casein was more effective than a mix of proteins representative of a western diet to prevent body weight gain and insulin resistance. This was explained in part by modifications of the gut microbiota. This finding represents the main conceptual basis of the present research program that is aimed to determine the impact of dairy protein from yogurt compared to a plant-based equivalent on body composition indicators including muscle mass and bone mineral density, in relation to the profile of the gut microbiota, the production of newly discovered protein-derived metabolites, and markers of metabolic health. This program will include a human and an animal component requiring the testing of these variables before and after a standardized intervention. The human component will be a clinical study consisting of a 12-week diet-based weight loss intervention in postmenopausal overweight women being randomly assigned to one of the three following groups: yogurt, plant-based yogurt, or kept on diet without supplements. The animal experimentation will permit to causally determine the implication of the gut microbiota in the protein effects following transfer of the human bacteria to germ free mice and validate the benefits seen in humans. It is anticipated that these two complementary investigative approaches will allow a thorough documentation of the impact of fermented dairy protein on body composition and functioning, a better understanding of the underlying mechanisms, and the identification of new biomarkers to better appreciate related health benefits.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Postmenopausal women (absence of menstruation for at least 1 year and FSH > 40 IU/L)
BMI between 27.0 and 39.9 kg/m²
Sedentary or moderately active
Disqualifiers
Body weight change greater than 5 kg in the 3 months preceding the study
Currently dieting or following specific dietary patterns
Previous or planned bariatric surgery
Food allergies or intolerances (particularly dairy proteins and lactose)
Trial design
Parallel
Treatments tested in this trial
Dairy yogurt
Dietary supplementDairy yogurt: two serving daily
Plant based yogurt
Dietary supplementPlant based yogurt: two servings daily
No yogurt
Dietary supplementNo yogurt: zero serving yogurt
Treatment groups
Trial outcomes
Primary outcomes
Change in bone health
Assessment of bone mineral density using Dual X-ray Absorptiometry scan
Change in bone health
Assessment of bone turnover biomarkers (osteocalcin, c-telopeptide, Amino terminal propeptide of type 1 procollagen) (all in ng\\mL)
Change in gut microbiota
Assessment of global variation of the fecal microbiota
Change in gut microbiota function
Assessment of short-chain fatty acid (SCFA) in feces
Secondary outcomes
Change in body weight
Change in anthropometric measures
Assessment of body mass index (BMI) using weight and height. These two measurements will be combined to calculate BMI in kg/m2
Change in anthropometric measure
Assessment of waist circumference
Change in body composition
Assessment of changes in lean mass, fat mass and visceral fat mass (all in grams) using body composition by Dual X-ray Absorptiometry scan
Sponsors and contacts
Click on the lead sponsor to view all of their trials.